Analgesics (Pharmacies) - Russia

  • Russia
  • Revenue in the Analgesics market is projected to reach US$0.53bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.11%, resulting in a market volume of US$0.68bn by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$3.65 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Russia has been experiencing significant growth in recent years, driven by various factors such as customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Analgesics (Pharmacies) market in Russia have been shifting towards a greater demand for over-the-counter (OTC) pain relief medications. This can be attributed to the convenience and accessibility of these products, as well as the increasing awareness among consumers about self-care and self-medication. Additionally, customers in Russia are also showing a preference for analgesic products that provide quick and effective relief from pain, without any major side effects. One of the key trends in the Analgesics (Pharmacies) market in Russia is the growing popularity of natural and herbal pain relief remedies. This trend is driven by the increasing consumer preference for natural and organic products, as well as the perception that these remedies are safer and have fewer side effects compared to traditional pharmaceutical products. As a result, there has been a rise in the availability and sales of natural analgesics in pharmacies across Russia. Another trend in the market is the increasing use of online platforms for purchasing analgesics. This trend is driven by the convenience and ease of online shopping, as well as the availability of a wide range of products and competitive prices. Online pharmacies and e-commerce platforms have witnessed significant growth in Russia, and this trend is expected to continue in the coming years. Local special circumstances also play a role in shaping the Analgesics (Pharmacies) market in Russia. The country has a large population, with a significant portion of the population suffering from various types of pain and seeking relief. This creates a high demand for analgesic products, both prescription and OTC, in pharmacies across the country. Additionally, the Russian government has been taking steps to improve access to healthcare and pharmaceutical products, which has further contributed to the growth of the market. Underlying macroeconomic factors also influence the development of the Analgesics (Pharmacies) market in Russia. The country has been experiencing stable economic growth in recent years, which has led to an increase in disposable income and improved living standards. This has resulted in higher healthcare expenditure and increased affordability of analgesic products. Furthermore, the aging population in Russia is also driving the demand for pain relief medications, as older individuals are more prone to chronic pain conditions. In conclusion, the Analgesics (Pharmacies) market in Russia is developing due to customer preferences for OTC pain relief medications, the growing popularity of natural and herbal remedies, the increasing use of online platforms for purchasing analgesics, local special circumstances such as a large population and government initiatives to improve healthcare access, and underlying macroeconomic factors such as stable economic growth and an aging population.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)